EGFR and neoplasm: In corticotroph tumor cells, these highly active USP8 mutants rescue epidermal growth factor receptor (EGFR) from ligand-induced ubiquitination and lysosomal degradation and potentiate its signaling resulting in enhanced ACTH synthesis [6].